ROCHE FINANCE LTD

Overview

• HeadquartersV8¹

See how the biggest companies compare on our leaderboards

Corporate structure

ROCHE FINANCE LTD sits at the top of its group. 8 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (7 companies). Each entity in the chart links to its source.

Stakes it holds

ROCHE FINANCE LTD has told the SEC it owns more than 5% of 7 companies, latest first (Schedules 13D and 13G).

• Entrada Therapeutics, Inc.SCHEDULE 13G/A Feb 14, 2022 to Feb 14, 2025²
• Aligos Therapeutics, Inc.SC 13G/A Nov 7, 2023³
• Eloxx Pharmaceuticals, Inc.SC 13G/A Feb 14, 2022 to Feb 13, 2023⁴
• Jasper Therapeutics, Inc.SC 13G/A Oct 4, 2021 to Feb 13, 2023⁵
• Allakos Inc.SC 13G/A Feb 14, 2022⁶
• Tempest Therapeutics, Inc.SC 13G/A Feb 14, 2022⁷
• Vaxcyte, Inc.SC 13G/A Feb 14, 2022⁸